NCT06481956 2024-07-01
T-DM1 Combined With CDK4/6 Inhibitor Ribociclib
Zhejiang Cancer Hospital
Phase 2 Enrolling by invitation
Clinical Trials
4 trialsNCT05856383 2023-05-12
HER2-VIP
Zhejiang Cancer Hospital
Recruiting
NCT04903652 2022-04-07
Pyrotinib Maleate Combined With Vinorelbine in the Treatment of HER2-positive Advanced Breast Cancer
Tianjin Medical University Cancer Institute and Hospital
Phase 2 Completed
NCT04963608 2021-07-15
RWS of Inetetamab HER2 Positive Advanced Breast Cancer
Shandong Cancer Hospital and Institute
Unknown